Intellia Therapeutics Names Graeme Bell Chief Financial Officer

Go back to Intellia Therapeutics Names Graeme Bell Chief Financial Officer
(NASDAQ: NTLA) Delayed: 12.02 --0 (-0%)
Previous Close $12.02    52 Week High $30.40 
Open $11.96    52 Week Low $11.86 
Day High $12.14    P/E N/A 
Day Low $11.69    EPS $0.00 
Volume 2,569,152